CID 16197322

Nh2-rrwcyrkcykgycyrkcrr-conh2

Structural Information

Molecular Formula
C116H177N41O23S4
SMILES
CC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CCCNC(=N)N)CC3=CC=C(C=C3)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CC4=CC=C(C=C4)O)CCCCN)CC5=CC=C(C=C5)O)CCCCN)CCCNC(=N)N)CC6=CC=C(C=C6)O)NC(=O)[C@H](CC7=CNC8=CC=CC=C87)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)N
InChI
InChI=1S/C116H177N41O23S4/c1-63(158)75(22-11-47-134-112(123)124)142-96(166)81(24-13-49-136-114(127)128)149-107(177)89-59-181-184-62-92(157-106(176)88(56-68-57-139-76-18-3-2-16-73(68)76)153-99(169)80(23-12-48-135-113(125)126)143-94(164)74(120)17-10-46-133-111(121)122)110(180)152-87(55-67-33-41-72(162)42-34-67)105(175)148-83(26-15-51-138-116(131)132)98(168)146-79(21-6-9-45-119)101(171)155-90-60-182-183-61-91(109(179)151-86(54-66-31-39-71(161)40-32-66)104(174)147-82(25-14-50-137-115(129)130)97(167)145-78(100(170)154-89)20-5-8-44-118)156-102(172)84(52-64-27-35-69(159)36-28-64)141-93(163)58-140-95(165)77(19-4-7-43-117)144-103(173)85(150-108(90)178)53-65-29-37-70(160)38-30-65/h2-3,16,18,27-42,57,74-75,77-92,139,159-162H,4-15,17,19-26,43-56,58-62,117-120H2,1H3,(H,140,165)(H,141,163)(H,142,166)(H,143,164)(H,144,173)(H,145,167)(H,146,168)(H,147,174)(H,148,175)(H,149,177)(H,150,178)(H,151,179)(H,152,180)(H,153,169)(H,154,170)(H,155,171)(H,156,172)(H,157,176)(H4,121,122,133)(H4,123,124,134)(H4,125,126,135)(H4,127,128,136)(H4,129,130,137)(H4,131,132,138)/t74-,75-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-/m0/s1
InChIKey
CXFBUVQGDYNUTP-QSLGZUFCSA-N
Compound name
(1R,4S,7S,10S,13R,18R,21S,24S,27S,30R,33S,39S,42S)-4,21,39-tris(4-aminobutyl)-13-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2S)-5-carbamimidamido-1-[[(3S)-6-carbamimidamido-2-oxohexan-3-yl]amino]-1-oxopentan-2-yl]-7,24-bis(3-carbamimidamidopropyl)-10,27,33,42-tetrakis[(4-hydroxyphenyl)methyl]-3,6,9,12,20,23,26,29,32,35,38,41,44-tridecaoxo-15,16,46,47-tetrathia-2,5,8,11,19,22,25,28,31,34,37,40,43-tridecazabicyclo[28.14.4]octatetracontane-18-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

2640.2825 Da
Monoisotopic Mass

-5.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2641.2898 201.6
[M+Na]+ 2663.2717 198.7
[M-H]- 2639.2752 202.3
[M+NH4]+ 2658.3163 198.4
[M+K]+ 2679.2457 196.6
[M+H-H2O]+ 2623.2798 185.0
[M+HCOO]- 2685.2807 198.9
[M+CH3COO]- 2699.2964 201.0
[M+Na-2H]- 2661.2572 232.4
[M]+ 2640.2820 175.1
[M]- 2640.2830 175.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.